Skip to content 
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas. more
| Dec '24 | Dec '25 | |||||
|---|---|---|---|---|---|---|
| Total Revenue | 15.64M | 32.04M | [{"date":"2024-12-31","value":48.83,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] | |||
| Cost of Revenue | 3.19M | 6.07M | [{"date":"2024-12-31","value":52.64,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] | |||
| Gross Profit | 12.45M | 25.98M | [{"date":"2024-12-31","value":47.94,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] | |||
| Gross Margin | 79.59% | 81.07% | [{"date":"2024-12-31","value":98.18,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] | |||
| Operating Expenses | 39.88M | 78.41M | [{"date":"2024-12-31","value":50.86,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] | |||
| Operating Income | (24.24M) | (46.37M) | [{"date":"2024-12-31","value":-2423629000,"profit":false},{"date":"2025-12-31","value":-4636790100,"profit":false}] | |||
| Total Non-Operating Income/Expense | (352.81K) | (124.84K) | [{"date":"2024-12-31","value":-35281100,"profit":false},{"date":"2025-12-31","value":-12483700,"profit":false}] | |||
| Pre-Tax Income | (24.59M) | (46.49M) | [{"date":"2024-12-31","value":-2458910100,"profit":false},{"date":"2025-12-31","value":-4649273800,"profit":false}] | |||
| Income Taxes | - | - | [{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] | |||
| Income After Taxes | - | - | [{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] | |||
| Income From Continuous Operations | (24.60M) | (46.50M) | [{"date":"2024-12-31","value":-2460301400,"profit":false},{"date":"2025-12-31","value":-4649818800,"profit":false}] | |||
| Income From Discontinued Operations | - | - | [{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] | |||
| Net Income | (24.60M) | (46.50M) | [{"date":"2024-12-31","value":-2460301400,"profit":false},{"date":"2025-12-31","value":-4649818800,"profit":false}] | |||
| EPS (Diluted) | - | - | [{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] | |||
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| MOBI | |
|---|---|
| ROA (LTM) | -82.52% |
| ROE (LTM) | -246.09% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| MOBI | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 13.53 |
| P/B | 0.00 |
| EV/R | 12.74 |
| EV/Ebitda | NM |
Mobia Medical, Inc. Common Stock (MOBI) share price today is $13.1
Yes, Indians can buy shares of Mobia Medical, Inc. Common Stock (MOBI) on Vested. To buy
Yes, you can purchase fractional shares of Mobia Medical, Inc. Common Stock (MOBI) via the Vested app. You can start investing in Mobia Medical, Inc. Common Stock (MOBI) with a minimum investment of $1.
You can invest in shares of Mobia Medical, Inc. Common Stock (MOBI) via Vested in three simple steps:
The 52-week high price of Mobia Medical, Inc. Common Stock (MOBI) is $14. The 52-week low price of Mobia Medical, Inc. Common Stock (MOBI) is $10.19.
The price-to-earnings (P/E) ratio of Mobia Medical, Inc. Common Stock (MOBI) is
The price-to-book (P/B) ratio of Mobia Medical, Inc. Common Stock (MOBI) is 0.00
The dividend yield of Mobia Medical, Inc. Common Stock (MOBI) is 0.00%
The market capitalization of Mobia Medical, Inc. Common Stock (MOBI) is $430.11M
The stock symbol (or ticker) of Mobia Medical, Inc. Common Stock is MOBI
Consider the share price of Mobia Medical, Inc. Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Mobia Medical, Inc. Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Mobia Medical, Inc. Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Mobia Medical, Inc. Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Mobia Medical, Inc. Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Mobia Medical, Inc. Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
